New doctorial cancer research: germline genetic alterations affecting CDKN2A, MDM2, and CDKN1A in melanoma and breast cancer patients

Crit Rev Oncog. 2007 Dec;13(3):261-2; discussion 263. doi: 10.1615/critrevoncog.v13.i3.30.

Author

Stian Knappskog¹

Affiliation

¹ Section of Oncology, Institute of Medicine, University of Bergen.

PMID: 18298387
DOI: 10.1615/critrevoncog.v13.i3.30

No abstract available

MeSH terms

Breast Neoplasms / genetics*
Cyclin-Dependent Kinase Inhibitor p21 / genetics*
Genes, p16*
Germ-Line Mutation*
Humans
Melanoma / genetics*
Proto-Oncogene Proteins c-mdm2 / genetics*

Substances

CDKN1A protein, human
Cyclin-Dependent Kinase Inhibitor p21
MDM2 protein, human
Proto-Oncogene Proteins c-mdm2